$QSI
Quantum-Si Inc

2023 Q1 Form 10-Q Financial Statement

#000114036123024185 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $254.0K $0.00 $0.00
YoY Change
Cost Of Revenue $130.0K $0.00
YoY Change
Gross Profit $124.0K $0.00
YoY Change
Gross Profit Margin 48.82%
Selling, General & Admin $11.18M $11.20M $8.369M
YoY Change 33.56% -16.43% 119.83%
% of Gross Profit 9014.52%
Research & Development $18.17M $18.16M $18.77M
YoY Change -3.22% 26.22% 135.46%
% of Gross Profit 14650.81%
Depreciation & Amortization $803.0K $795.0K $452.0K
YoY Change 77.65% 141.64% 112.21%
% of Gross Profit 647.58%
Operating Expenses $29.35M $29.36M $27.14M
YoY Change 8.12% 5.65% 130.41%
Operating Profit -$29.22M -$27.14M
YoY Change 7.67% 130.41%
Interest Expense $2.219M $2.013M $855.0K
YoY Change 159.53% 11.34%
% of Operating Profit
Other Income/Expense, Net $3.000M $3.690M -$11.54M
YoY Change -126.0% -207.27%
Pretax Income -$23.61M -$33.14M -$35.18M
YoY Change -32.88% 12.64% 198.62%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.61M -$33.14M -$35.18M
YoY Change -32.88% 12.64% 198.62%
Net Earnings / Revenue -9295.67%
Basic Earnings Per Share -$0.17 -$0.25
Diluted Earnings Per Share -$0.17 -$0.24 -$0.25
COMMON SHARES
Basic Shares Outstanding 140.3M 138.6M
Diluted Shares Outstanding 140.3M 138.6M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $322.1M $351.3M $434.8M
YoY Change -25.92% -25.46% 73453.03%
Cash & Equivalents $81.66M $84.32M $34.98M
Short-Term Investments $240.4M $267.0M $399.8M
Other Short-Term Assets $6.135M $6.873M $4.985M
YoY Change 23.07% 17.13% 2938.52%
Inventory $1.708M $0.00
Prepaid Expenses
Receivables $82.00K $0.00
Other Receivables $0.00
Total Short-Term Assets $330.0M $358.2M $439.8M
YoY Change -24.96% -24.94% 58134.22%
LONG-TERM ASSETS
Property, Plant & Equipment $18.20M $16.85M $26.19M
YoY Change -30.49% 89.14%
Goodwill $0.00
YoY Change -100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $697.0K $697.0K $690.0K
YoY Change 1.01% 1.01%
Total Long-Term Assets $35.01M $33.30M $36.36M
YoY Change -3.72% 27.82% -68.38%
TOTAL ASSETS
Total Short-Term Assets $330.0M $358.2M $439.8M
Total Long-Term Assets $35.01M $33.30M $36.36M
Total Assets $365.0M $391.5M $476.1M
YoY Change -23.34% -22.2% 311.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.657M $3.903M $4.293M
YoY Change -38.11% 15.03% 167.4%
Accrued Expenses $7.439M $11.80M $9.752M
YoY Change -23.72% 45.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.10M $15.71M $14.05M
YoY Change -28.12% 36.24% 774.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $24.00K $0.00 $20.22M
YoY Change -99.88% -100.0% 18.44%
Total Long-Term Liabilities $24.00K $0.00 $20.22M
YoY Change -99.88% -100.0% 18.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.10M $15.71M $14.05M
Total Long-Term Liabilities $24.00K $0.00 $20.22M
Total Liabilities $26.02M $32.78M $34.26M
YoY Change -24.05% 25.15% 83.46%
SHAREHOLDERS EQUITY
Retained Earnings -$423.3M -$399.7M
YoY Change 49.56%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $339.0M $358.7M $441.9M
YoY Change
Total Liabilities & Shareholders Equity $365.0M $391.5M $476.1M
YoY Change -23.34% -22.2% 311.32%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$23.61M -$33.14M -$35.18M
YoY Change -32.88% 12.64% 198.62%
Depreciation, Depletion And Amortization $803.0K $795.0K $452.0K
YoY Change 77.65% 141.64% 112.21%
Cash From Operating Activities -$28.70M -$19.58M -$23.23M
YoY Change 23.54% 10.66% 116.37%
INVESTING ACTIVITIES
Capital Expenditures $2.574M $3.500M -$2.500M
YoY Change -202.96% -202.67% 400.0%
Acquisitions
YoY Change
Other Investing Activities $29.50M $29.00M $24.20M
YoY Change 21.91% -550.47%
Cash From Investing Activities $26.04M $25.50M $21.70M
YoY Change 20.01% -358.97% -4439.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 138.0K 730.0K
YoY Change -100.0% -88.73% -25.51%
NET CHANGE
Cash From Operating Activities -28.70M -19.58M -23.23M
Cash From Investing Activities 26.04M 25.50M 21.70M
Cash From Financing Activities 0.000 138.0K 730.0K
Net Change In Cash -2.659M 6.056M -801.0K
YoY Change 231.96% -123.01% -92.19%
FREE CASH FLOW
Cash From Operating Activities -$28.70M -$19.58M -$23.23M
Capital Expenditures $2.574M $3.500M -$2.500M
Free Cash Flow -$31.27M -$23.08M -$20.73M
YoY Change 50.86% 61.57% 102.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
847000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
697000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
697000
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2219000
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
855000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23611000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35175000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35175000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
138619929
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
477034000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35175000
CY2022Q1 qsi Stock Issued During Period Value Stock Options Exercised And Restricted Stock Awards Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardsVested
730000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-714000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
358706000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-23611000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3908000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
339003000
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001816431
CY2020Q3 qsi Number Of Warrants Issued Per Unit Issued
NumberOfWarrantsIssuedPerUnitIssued
0.33
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-23611000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140280332
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140280332
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
138619929
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441875000
CY2023Q1 qsi Stock Issued During Period Value Stock Options Exercised And Restricted Stock Awards Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardsVested
0
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1580000
CY2023Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
5110000
CY2022Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-11511000
CY2023Q1 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-2168000
CY2022Q1 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-50000
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2219000
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
855000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2023Q1 qsi Standard Product Warranty Warranty Period
StandardProductWarrantyWarrantyPeriod
P12M
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P2Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
333000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
443000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
111000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
73000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
69000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
41000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.30
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.70
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25204000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23052000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7001000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6203000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18203000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16849000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
803000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
452000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2828000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5548000
CY2023Q1 qsi Accrued Contracted Services Current
AccruedContractedServicesCurrent
1918000
CY2022Q4 qsi Accrued Contracted Services Current
AccruedContractedServicesCurrent
3616000
CY2023Q1 qsi Accrued Acquisition Related Fees Current
AccruedAcquisitionRelatedFeesCurrent
377000
CY2022Q4 qsi Accrued Acquisition Related Fees Current
AccruedAcquisitionRelatedFeesCurrent
343000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
875000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
839000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
88000
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
6033000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10434000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
853000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
725000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
129000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
104000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
394000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
286000
CY2023Q1 us-gaap Lease Cost
LeaseCost
1376000
CY2022Q1 us-gaap Lease Cost
LeaseCost
1115000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1059000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
310000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8490000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3225000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4394000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4507000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4590000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4554000
CY2023Q1 qsi Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
12811000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34081000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8274000
CY2023Q1 qsi Lease Incentives
LeaseIncentives
9104000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
16703000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3908000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-714000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-23611000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35175000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23611000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23611000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35175000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-35175000
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
140280332
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
138619929
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140280332
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140280332
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
138619929
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
138619929
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28653077
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17645158
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
605000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
996000
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
391000
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2647000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.12
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
813000
CY2023Q1 qsi Other Commitment Annual Minimum Fixed Payments
OtherCommitmentAnnualMinimumFixedPayments
211000
CY2022Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
380000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001140361-23-024185-index-headers.html Edgar Link pending
0001140361-23-024185-index.html Edgar Link pending
0001140361-23-024185.txt Edgar Link pending
0001140361-23-024185-xbrl.zip Edgar Link pending
brhc20052605_10q.htm Edgar Link pending
brhc20052605_ex31-1.htm Edgar Link pending
brhc20052605_ex31-2.htm Edgar Link pending
brhc20052605_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsi-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
qsi-20230331_cal.xml Edgar Link unprocessable
qsi-20230331_def.xml Edgar Link unprocessable
qsi-20230331_lab.xml Edgar Link unprocessable
qsi-20230331_pre.xml Edgar Link unprocessable
brhc20052605_10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending